November 2023 Br J Cardiol 2023;30:148 doi:10.5837/bjc.2023.043
Usman Hanif Bhatti, Khalid Naseeb, Muhammad Nauman Khan, Vashu Mal, Muhammad Asad Baqai, Musa Karim, Muhammad Ashar Khan, Tahir Saghir
Introduction ST-elevation myocardial infarction (STEMI) is an acute ischaemic event associated with an increased risk of clinical complications, poor recovery, and adverse cardiovascular events.1 Owing to the recent development and advancements in management, outcomes of STEMI patients have improved significantly.2 Primary percutaneous coronary intervention (PCI) remains the recommended treatment option by both European and American clinical practice guidelines.3,4 In addition to improvements in the management strategy, risk stratification of patients with STEMI improved extensively with the introduction of various risk-stratification modali
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits